Coleman Rotstein - Concepedia

Author

Coleman Rotstein

Also Known As

C Rotstein, C. ROTSTEIN, C. Rotstein, COLEMAN ROTSTEIN, Coleman MF Rotstein, Coleman M. F. Rotstein, Coleman M. Rotstein, Coleman M.F. Rotstein, Coleman Rotstein, David Grant

443

Publications

9.6K

Citations

H-Index

Concepts

All Affiliations

University of Toronto University Health Network McMaster University University at Buffalo, State University of New York Roswell Park Comprehensive Cancer Center

About

Coleman Rotstein is an author at University of Toronto specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	33	2.6K
2	Health Sciences	9	9	946
3	Public Health	1	1	13
4	Allergy	1	1	13
5	Biology	1	1	28

Coleman Rotstein

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis Jorge Mora-Duarte, Robert F. Betts, Coleman Rotstein, New England Journal of Medicine	2002	1.4K
Anidulafungin versus Fluconazole for Invasive Candidiasis Annette C. Reboli, Coleman Rotstein, Peter G. Pappas, New England Journal of Medicine	2007	888
Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008 Michael A. Pfaller, David R. Andes, Daniel J. Diekema, PLoS ONE Path AllianceAntifungal AgentHealth SciencesFungal PathogenAntifungal Agents	2014	398
Emerging fungal infections in immunocompromised patients Chian-Yong Low, Coleman Rotstein F1000 Medicine Reports Molecular Diagnostic TechniquesAntifungal AgentAutoimmune DiseaseAntifungal AgentsInvasive Mold Infections	2011	310
Clinical Practice Guidelines for Hospital‐Acquired Pneumonia and Ventilator‐Associated Pneumonia in Adults Coleman Rotstein, Gerald A. Evans, Abraham Born, Canadian Journal of Infectious Diseases and Medical Microbiology Pulmonary CareResistant PathogensVentilator‐associated PneumoniaClinical Practice GuidelinesHospital‐acquired Pneumonia	2007	276
Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy Coleman Rotstein, Eric J. Bow, Michél Laverdière, Clinical Infectious Diseases PharmacotherapyAntimicrobial ChemotherapyDrug ResistanceFluconazole ProphylaxisNeutropenic Cancer Patients	1999	266
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients Peter Phillips, Stephen Shafran, Gary Garber, European Journal of Clinical Microbiology & Infectious Diseases Antifungal AgentNon-neutropenic PatientsAntifungal AgentsPharmacologyClinical Mycology	1997	220
A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients Yoichiro Natori, Mika Shiotsuka, Jaclyn Slomovic, Clinical Infectious Diseases	2017	178
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial Bart Jan Kullberg, Claudio Viscoli, Peter G. Pappas, Clinical Infectious Diseases	2018	173
A practical guide for the diagnosis and treatment of acute sinusitis. Donald E. Low, Martin Desrosiers, James McSherry, PubMed	1997	146

Page 1